Cloxaclillin nanostructured formulation for control of clinical bovine keratoconjunctivitis.

Vista sencilla de ítem
dc.contributorALESSANDRO DE SA GUIMARAES, CNPGL; CARLA CHRISTINE LANGE, CNPGL; IOWA STATE UNIVERSITY; UFOP; UFOP; GUILHERME NUNES DE SOUZA, CNPGL; LETICIA CALDAS MENDONCA, CNPGL; MARIA APARECIDA V PAIVA E BRITO, CNPGL; JULIANA CARINE GERN, CNPGL; HUMBERTO DE MELLO BRANDAO, CNPGL.
dc.creatorGUIMARAES, A. S.
dc.creatorLANGE, C. C.
dc.creatorO'CONNOR, A. N.
dc.creatorCASTANHEIRA, R. G.
dc.creatorMOSQUEIRA, V. C. F.
dc.creatorSOUZA, G. N. de
dc.creatorMENDONCA, L. C.
dc.creatorBRITO, M. A. V. P. e
dc.creatorGERN, J. C.
dc.creatorBRANDAO, H. de M.
dc.date2025-06-25T21:23:19Z
dc.date2025-06-25T21:23:19Z
dc.date2013-02-07
dc.date2012
dc.date.accessioned2026-07-07T04:00:08Z
dc.descriptionInfectious bovine keratoconjunctivitis or' pinkeye' is a widespread, contagious ocular disease of cattle, mainly dairy cattle, that is caused by the Gram negative bacterium Moraxella bovis. Its treatment consists of parenteral or topic antibiotic therapy, the last route is used in lactating cows to reduce milk discart. However, cases of treatment failure are common, because the lacrimation removes the antibiotic.
dc.formatp. 61.
dc.identifierIn: SIMPÓSIO EMBRAPA LABEX EUA DE SANIDADE ANIMAL, 2., 2012, Brasília, DF. Anais... Brasília, DF: Embrapa Estudos e Capacitação, 2012.
dc.identifierhttp://www.alice.cnptia.embrapa.br/alice/handle/doc/948717
dc.identifier.urihttp://hdl.handle.net/123456789/450218
dc.languageeng
dc.rightsopenAccess
dc.subjectInfecção queratoconjuntivite
dc.subjectNanoparticulas mucoadesivas
dc.subjectMoraxella Bovis
dc.titleCloxaclillin nanostructured formulation for control of clinical bovine keratoconjunctivitis.
dc.typeResumo em anais e proceedings

Archivos

Colecciones

Embrapa Vacas Lecheras (CNPGL)